Form 4: Phreesia Director Lainie Goldstein Acquires 744 Shares

Phreesia Director Lainie Goldstein acquired 744 common shares at $13.43 each through a deferred compensation program.

Summary

• Lainie Goldstein, a Director of Phreesia, Inc. (PHR), acquired 744 shares of common stock.
• The acquisition occurred on January 30, 2026, at a price of $13.43 per share.
• These shares were granted as Deferred Stock Units (DSUs) as part of Phreesia's Non-Employee Director Deferred Compensation Program.
• The DSUs were received in lieu of an an annual cash retainer and are awarded quarterly in arrears.
• Following this transaction, Lainie Goldstein beneficially owns 50,110 shares of Phreesia common stock directly.
• The underlying common stock will be received 90 days after Goldstein ceases to serve on the Board and incurs a "separation from service" as per Section 409A of the Internal Revenue Code.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as it indicates a director's continued investment in the company through a compensation program, aligning their interests with shareholders.

Positives

• Director Lainie Goldstein's acquisition of 744 shares demonstrates continued alignment of interests with shareholders.
• The use of a deferred compensation program for directors can encourage long-term commitment and reduce immediate cash outflow for the company.

Future Outlook

The filing indicates that the underlying common stock for the Deferred Stock Units will be received 90 days after the director ceases to serve on the Board and incurs a "separation from service" within the meaning of Section 409A of the Internal Revenue Code.

Industry Context

StockSavvy.ai notes that director stock acquisitions, especially through deferred compensation plans, are a common practice across various industries to align director incentives with long-term shareholder value. This particular transaction reflects a standard compensation mechanism for non-employee directors.

Comparison to Industry Standards

• The use of Deferred Stock Units (DSUs) as part of non-employee director compensation is a widely adopted practice among publicly traded companies, including peers in the healthcare technology sector like Veeva Systems (VEEV) or Health Catalyst (HCAT), to foster long-term alignment and retention.
• The specific grant amount of 744 shares at $13.43, while specific to Phreesia's compensation structure, is consistent with typical equity components of director compensation packages in companies of similar market capitalization, which often blend cash retainers with equity awards.

Corporate Governance

Related Party Transactions

• The grant of Deferred Stock Units to Director Lainie Goldstein in lieu of a cash retainer is a related party transaction as it involves compensation to a member of the Board of Directors.

Stakeholder Impact

• Shareholders: The transaction aligns the director's interests with shareholders by increasing their direct equity stake, potentially fostering more long-term decision-making.

Next Steps

• Lainie Goldstein will receive the underlying common stock 90 days after ceasing to serve as a member of the Board of Directors and incurring a "separation from service."

Key Dates

Recommendation

This Form 4 filing details a routine director compensation transaction and does not provide sufficient new information to warrant a change in investment recommendation. It primarily confirms ongoing director alignment through equity compensation.

Keywords

Phreesia, PHR, Lainie Goldstein, Director, Stock Acquisition, Form 4, SEC Filing, Deferred Stock Units, DSU, Insider Trading, Compensation Program